Summit Therapeutics Inc.
Summit Therapeutics specializes in biopharma discovery, development and commercialization of patient-focused therapies. Its lead bispecific antibody, ivonescimab, blocks PD‑1 and targets angiogenesis and is in Phase III trials for non‑small cell lung cancer. Founded 2003, Miami.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 159
- HQ: Miami
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.